HARPER MOLLY sold 91.9% of their position (26.75K shares) of CATALYST PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $621.9K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common stock, par value $0.001 per share
Shares
+20K
Price / share
$5.78
Trade value
$115.60K
% of position
Common stock, par value $0.001 per share
Shares
−15.53K
Price / share
$23.20
Trade value
$360.20K
% of position
Common stock, par value $0.001 per share
Shares
−4.47K
Price / share
$23.73
Trade value
$106.16K
% of position
Common stock, par value $0.001 per share
Shares
−6.75K
Price / share
$23.06
Trade value
$155.56K
% of position
Net shares
−6.75K
Net value
-$506.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per share Direct | 12/12/2025 | M · Option Exercise | +20K | $5.78 | $115.60K | 219.6% | 9.11K | 29.11K |
| Common stock, par value $0.001 per share Direct | 12/12/2025 | S · Sale | −15.53K | $23.20 | $360.20K | 53.3% | 29.11K | 13.58K |
| Common stock, par value $0.001 per share Direct | 12/12/2025 | S · Sale | −4.47K | $23.73 | $106.16K | 32.9% | 13.58K | 9.11K |
| Common stock, par value $0.001 per share Direct | 12/12/2025 | S · Sale | −6.75K | $23.06 | $155.56K | 74.1% | 9.11K | 2.36K |
| Total | −6.75K | -$506.32K | ||||||
Options to purchase common stock
Common Stock
20K shares
Shares
−20K
Strike price
5.78
Held after
128.50K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Options to purchase common stock Direct | Common Stock20K shares | 12/12/2025 | M · Option Exercise | −20K | 5.78 | — | 128.50K |